Skip to main content
logo
CytomX Therapeutics, Inc. (CTMX)
NASDAQ: CTMX · Real-Time Price · USD
4.350
+0.090 (2.11%)
Jan 9, 2026, 2:12 PM EST - Market open

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202011 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2011 - 2019
Probody Therapeutics
138.10M
Log In
Log In
Log In
Log In
Upgrade
Probody Therapeutics Growth
36.45%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202011 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2011 - 2019
United States
138.10M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
36.45%
Log In
Log In
Log In
Log In
Upgrade